{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T09:36:52Z","timestamp":1793266612862,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["114-SS0022"],"award-info":[{"award-number":["114-SS0022"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009048","name":"Mrs. Hsiu-Chin Lee Kidney Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jfma.2025.01.019","type":"journal-article","created":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T23:14:19Z","timestamp":1737933259000},"page":"261-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Use of iodinated and gadolinium-based contrast media in patients with chronic kidney disease: Consensus statements from nephrologists, cardiologists, and radiologists at National Taiwan University Hospital"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9945-5254","authenticated-orcid":false,"given":"Kuan-Chieh","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2995-4952","authenticated-orcid":false,"given":"Li-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8738-9463","authenticated-orcid":false,"given":"Szu-Yu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenq-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0628-1950","authenticated-orcid":false,"given":"Yu-Ching","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7405-0858","authenticated-orcid":false,"given":"Jiun-Yang","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien-Li","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Jui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ching","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2025.01.019_bib1","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jfma.2025.01.019_bib2","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s00330-017-5246-5","article-title":"Post-contrast acute kidney injury - Part 1: definition, clinical features, incidence, role of contrast medium and risk factors : recommendations for updated ESUR Contrast Medium Safety Committee guidelines","volume":"28","author":"van der Molen","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jfma.2025.01.019_bib3","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.23.30037","article-title":"Risk of acute kidney injury following IV iodinated contrast media exposure: 2023 update, from the AJR special series on contrast media","volume":"223","author":"McDonald","year":"2024","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jfma.2025.01.019_bib4","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1056\/NEJMra1805256","article-title":"Contrast-associated acute kidney injury","volume":"380","author":"Mehran","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2025.01.019_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2215\/CJN.02600607","article-title":"Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy","volume":"3","author":"Heyman","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2025.01.019_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrneph.2016.196","article-title":"Understanding and preventing contrast-induced acute kidney injury","volume":"13","author":"F\u00e4hling","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jfma.2025.01.019_bib7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1523-1755.2003.00059.x","article-title":"Radiographic contrast media-induced tubular injury: evaluation of oxidant stress and plasma membrane integrity","volume":"64","author":"Zager","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2025.01.019_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/249810","article-title":"Molecular mechanisms of renal cellular nephrotoxicity due to radiocontrast media","volume":"2014","author":"Michael","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jfma.2025.01.019_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1681\/ASN.V3158","article-title":"Radiocontrast agents induce endothelin release in vivo and in vitro","volume":"3","author":"Heyman","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2025.01.019_bib10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1148\/radiol.12121394","article-title":"Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material","volume":"267","author":"Davenport","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.jfma.2025.01.019_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1148\/radiol.13130775","article-title":"Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate","volume":"271","author":"McDonald","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.jfma.2025.01.019_bib12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1148\/radiol.2021204446","article-title":"Intravenous CT contrast media and acute kidney injury: a multicenter emergency department-based study","volume":"301","author":"Su","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.jfma.2025.01.019_bib13","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0140-6736(17)30057-0","article-title":"Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial","volume":"389","author":"Nijssen","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2025.01.019_bib14","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1710933","article-title":"Outcomes after angiography with sodium bicarbonate and acetylcysteine","volume":"378","author":"Weisbord","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2025.01.019_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.xkme.2020.01.001","article-title":"Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the national kidney foundation","volume":"2","author":"Davenport","year":"2020","journal-title":"Kidney Med"},{"key":"10.1016\/j.jfma.2025.01.019_bib16","doi-asserted-by":"crossref","first-page":"8432","DOI":"10.1007\/s00330-022-08916-y","article-title":"Risk of acute kidney injury after contrast-enhanced computerized tomography: a systematic review and meta-analysis of 21 propensity score-matched cohort studies","volume":"32","author":"Obed","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jfma.2025.01.019_bib17","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/01.CIR.0000016043.87291.33","article-title":"Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention","volume":"105","author":"Rihal","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2025.01.019_bib18","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222321","article-title":"Contrast-enhanced CT and acute kidney injury: risk stratification by diabetic status and kidney function","volume":"307","author":"Lee","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.jfma.2025.01.019_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa021833","article-title":"Nephrotoxic effects in high-risk patients undergoing angiography","volume":"348","author":"Aspelin","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2025.01.019_bib20","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jacc.2006.06.047","article-title":"Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial","volume":"48","author":"Jo","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2025.01.019_bib21","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.16021","article-title":"Development and validation of a model for predicting the risk of acute kidney injury associated with contrast volume levels during percutaneous coronary intervention","volume":"2","author":"Huang","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jfma.2025.01.019_bib22","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1148\/radiol.2019182220","article-title":"Kidney injury after intravenous versus intra-arterial contrast agent in patients suspected of having coronary artery disease: a randomized trial","volume":"292","author":"Sch\u00f6nenberger","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.jfma.2025.01.019_bib23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s00134-017-4699-y","article-title":"Post-contrast acute kidney injury in intensive care unit patients: a propensity score-adjusted study","volume":"43","author":"McDonald","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jfma.2025.01.019_bib24","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(14)60689-9","article-title":"Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial","volume":"383","author":"Brar","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2025.01.019_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jamainternmed.2019.7428","article-title":"Effect of No prehydration vs sodium bicarbonate prehydration prior to contrast-enhanced computed tomography in the prevention of postcontrast acute kidney injury in adults with chronic kidney disease: the Kompas randomized clinical trial","volume":"180","author":"Timal","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jfma.2025.01.019_bib26","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0002-9343(89)90437-3","article-title":"Dosing of contrast material to prevent contrast nephropathy in patients with renal disease","volume":"86","author":"Cigarroa","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.jfma.2025.01.019_bib27","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jacc.2011.05.023","article-title":"Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions","volume":"58","author":"Gurm","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2025.01.019_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018890","article-title":"Refining safe contrast limits for preventing acute kidney injury after percutaneous coronary intervention","volume":"10","author":"Yuan","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jfma.2025.01.019_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2022.110221","article-title":"Image quality assessment of artificial intelligence iterative reconstruction for low dose aortic CTA: a feasibility study of 70 kVp and reduced contrast medium volume","volume":"149","author":"Li","year":"2022","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jfma.2025.01.019_bib30","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1038\/sj.ki.5000371","article-title":"Dialysis and iodinated contrast media","author":"Deray","year":"2006","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jfma.2025.01.019_bib31","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jacc.2007.05.033","article-title":"Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial","volume":"50","author":"Lee","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2025.01.019_bib32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00392-007-0473-4","article-title":"A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial","volume":"96","author":"Reinecke","year":"2007","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jfma.2025.01.019_bib33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.amjmed.2011.06.029","article-title":"Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review","volume":"125","author":"Cruz","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.jfma.2025.01.019_bib34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/jama.2022.13382","article-title":"Effect of clinical decision support with audit and feedback on prevention of acute kidney injury in patients undergoing coronary angiography: a randomized clinical trial","volume":"328","author":"James","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2025.01.019_bib35","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1442-2042.2012.03042.x","article-title":"Recent topics related to nephrogenic systemic fibrosis associated with gadolinium\u2010based contrast agents","volume":"19","author":"Kitajima","year":"2012","journal-title":"Int J Urol"},{"key":"10.1016\/j.jfma.2025.01.019_bib36","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/art.24471","article-title":"Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agents","volume":"60","author":"Wermuth","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfma.2025.01.019_bib37","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.00166.2016","article-title":"Pathophysiology of gadolinium-associated systemic fibrosis","volume":"311","author":"Wagner","year":"2016","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.jfma.2025.01.019_bib38","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1148\/radiol.2019182916","article-title":"A systematic review of 639 patients with biopsy-confirmed nephrogenic systemic fibrosis","volume":"292","author":"Attari","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.jfma.2025.01.019_bib39","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1053\/j.ajkd.2020.07.012","article-title":"Risks and options with gadolinium-based contrast agents in patients with CKD: a review","volume":"77","author":"Rudnick","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jfma.2025.01.019_bib40","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.jaad.2005.04.024","article-title":"Nephrogenic fibrosing dermopathy\/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure","volume":"54","author":"Kucher","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jfma.2025.01.019_bib41","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1002\/art.23696","article-title":"Imatinib mesylate treatment of nephrogenic systemic fibrosis","volume":"58","author":"Kay","year":"2008","journal-title":"Arthritis Rheum: Official Journal of the American College of Rheumatology"},{"key":"10.1016\/j.jfma.2025.01.019_bib42","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1365-2133.2003.05795.x","article-title":"Nephrogenic fibrosing dermopathy: response to high\u2010dose intravenous immunoglobulin","volume":"150","author":"Chung","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jfma.2025.01.019_bib43","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ndt\/gfk062","article-title":"Gadolinium\u2013a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?","volume":"21","author":"Grobner","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jfma.2025.01.019_bib44","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/jca.20170","article-title":"Extracorporeal photopheresis improves nephrogenic fibrosing dermopathy\/nephrogenic systemic fibrosis: three case reports and review of literature","volume":"23","author":"Mathur","year":"2008","journal-title":"J Clin Apher: The Official Journal of the American Society for Apheresis"},{"key":"10.1016\/j.jfma.2025.01.019_bib45","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/ndt\/gfq693","article-title":"Renal transplantation for nephrogenic systemic fibrosis: a case report and review of the literature","volume":"26","author":"Cuffy","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jfma.2025.01.019_bib46","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11604-006-0055-9","article-title":"Dialyzability of gadodiamide in hemodialysis patients","volume":"24","author":"Saitoh","year":"2006","journal-title":"Radiat Med"},{"key":"10.1016\/j.jfma.2025.01.019_bib47","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1076-6332(98)80191-8","article-title":"Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis","volume":"5","author":"Joffe","year":"1998","journal-title":"Acad Radiol"},{"key":"10.1016\/j.jfma.2025.01.019_bib48","series-title":"Seminars in dialysis","first-page":"145","article-title":"NSF: what we KNOW and what we need to KNOW: dialytic therapies to prevent NSF following gadolinium exposure in high\u2010risk patients","author":"Rodby","year":"2008"},{"key":"10.1016\/j.jfma.2025.01.019_bib49","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10534-008-9135-x","article-title":"Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review","volume":"21","author":"Port","year":"2008","journal-title":"Biometals"},{"key":"10.1016\/j.jfma.2025.01.019_bib50","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1148\/rg.2020190110","article-title":"Gadolinium deposition and nephrogenic systemic fibrosis: a radiologist's primer","volume":"40","author":"Mathur","year":"2020","journal-title":"Radiographics"},{"key":"10.1016\/j.jfma.2025.01.019_bib51","unstructured":"American College of Radiology (ACR) website. ACR committee on Drugs and contrast media. ACR manual on contrast media 2023. www.acr.org\/-\/media\/ACR\/files\/clinical-resources\/contrast_media.pdf. p103-107. [Accessed 10 April 2023] Published 2023."},{"key":"10.1016\/j.jfma.2025.01.019_bib52","unstructured":"American College of Radiology (ACR) website. ACR committee on Drugs and contrast media. ACR manual on contrast media 2024. https:\/\/www.acr.org\/Clinical-Resources\/Contrast-Manual. p78-80. [Accessed 26 November 2024]."},{"key":"10.1016\/j.jfma.2025.01.019_bib54","doi-asserted-by":"crossref","first-page":"110","DOI":"10.7326\/M20-0299","article-title":"Risk for nephrogenic systemic fibrosis after exposure to newer gadolinium agents: a systematic review","volume":"173","author":"Lunyera","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jfma.2025.01.019_bib56","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamainternmed.2019.5284","article-title":"Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium-based contrast agent: a systematic review and meta-analysis","volume":"180","author":"Woolen","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jfma.2025.01.019_bib57","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.acra.2004.07.015","article-title":"Gadolinium contrast media are more nephrotoxic than a low osmolar iodine medium employing doses with equal X-ray attenuation in renal arteriography: an experimental study in pigs","volume":"11","author":"Elmst\u00e5hl","year":"2004","journal-title":"Acad Radiol"},{"key":"10.1016\/j.jfma.2025.01.019_bib58","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1093\/ndt\/gfh272","article-title":"Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients","volume":"19","author":"Erley","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jfma.2025.01.019_bib59","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1007\/s00330-006-0357-4","article-title":"Gadolinium contrast media are more nephrotoxic than iodine media. The importance of osmolality in direct renal artery injections","volume":"16","author":"Elmst\u00e5hl","year":"2006","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jfma.2025.01.019_bib60","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jvir.2022.11.022","article-title":"Adverse events associated with intra-arterial administration of gadolinium-based contrast agents: a systematic review and meta-analysis","volume":"34","author":"MacLeod","year":"2023","journal-title":"J Vasc Intervent Radiol"},{"key":"10.1016\/j.jfma.2025.01.019_bib61","first-page":"175","article-title":"Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures","volume":"67","author":"Briguori","year":"2006","journal-title":"Cathet Cardiovasc Interv"},{"key":"10.1016\/j.jfma.2025.01.019_bib62","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0741-5214(03)00315-X","article-title":"Safety of gadolinium contrast angiography in patients with chronic renal insufficiency","volume":"38","author":"Sam","year":"2003","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jfma.2025.01.019_bib63","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/ndt\/gfi304","article-title":"The safety of gadolinium in patients with stage 3 and 4 renal failure","volume":"21","author":"Erg\u00fcn","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jfma.2025.01.019_bib64","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3109\/0886022X.2011.599911","article-title":"Risk of acute kidney injury after exposure to gadolinium-based contrast in patients with renal impairment","volume":"33","author":"Chien","year":"2011","journal-title":"Ren Fail"},{"key":"10.1016\/j.jfma.2025.01.019_bib65","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.5858\/2006-130-1354-AGCMNA","article-title":"Are gadolinium-based contrast media nephrotoxic? A renal biopsy study","volume":"130","author":"Akgun","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jfma.2025.01.019_bib66","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s00330-011-2225-0","article-title":"Contrast induced nephropathy: updated ESUR contrast media safety committee guidelines","volume":"21","author":"Stacul","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jfma.2025.01.019_bib67","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1148\/radiol.2019191163","article-title":"Differences in nephrotoxicity between modes of iodinated contrast material administration in patients suspected of having coronary artery disease","volume":"292","author":"Einstein","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.jfma.2025.01.019_bib68","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/RLI.0000000000000298","article-title":"Acute kidney injury after intravenous versus intra-arterial contrast material administration in a paired cohort","volume":"51","author":"McDonald","year":"2016","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jfma.2025.01.019_bib69","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMoa2200963","article-title":"CT or invasive coronary angiography in stable chest Pain","volume":"386","author":"Maurovich-Horvat","year":"2022","journal-title":"N Engl J Med"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966462500035X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966462500035X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:37:08Z","timestamp":1777592228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092966462500035X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S092966462500035X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2025.01.019","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of iodinated and gadolinium-based contrast media in patients with chronic kidney disease: Consensus statements from nephrologists, cardiologists, and radiologists at National Taiwan University Hospital","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2025.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}